Forensic Analysis · Automotive / Vehicle Manufacturing · as of Aug 9, 2026

Dorman Products, Inc. (DORM)

A forensic read on Dorman Products, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

C · Mixed — selective

Forensic grade

Safe

Financial health

9.6

Distress distance

Clean

Earnings quality

Forensic signals

18.8

P / E (ttm)

13.8%

ROE

$4.2B

Market cap

6.0%

Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Dorman Products, Inc. earns a C (Mixed — selective) forensic quality grade, and its balance-sheet distress test reads 9.6, placing it in the Safe zone. 4 forensic signals were flagged in its latest SEC filings, led by inventory days.

What the filings flag

247d

FY2024→FY2025

Inventory days. Days inventory outstanding moved from 204 to 247 FY2024→FY2025 (against cost of goods sold; inventory +35% vs +2% in cost of sales). Inventory is outrunning what's being sold — a flag for softening demand or obsolescence risk ahead.

177% of FCF

FY2012

Shareholder returns. Returned $55M to shareholders (buybacks + dividends) in FY2012 — 177% of free cash flow. More than free cash flow generated — and beyond operating cash too, so the extra is coming from debt or cash reserves, which isn't sustainable indefinitely.

$57M

FY2025–FY2025

Goodwill impairments. Took $57M of goodwill writedowns across 1 year (FY2025 ($57M)) — about 28% of net income over the span. A large writedown means an acquisition turned out worth far less than was paid — a real mark against M&A discipline.

11.2%

FY2025

Return on invested capital. Return on invested capital is 11.2% in the latest fiscal year and rising from 8% — a modest positive spread over its ~9% cost of capital — growth adds value, though not dramatically.

Key fundamentals

Latest Revenue$2.13B

Revenue Growth YoY+6.0%

Revenue CAGR (3yr)+7.1%

Net Margin9.6%

Free Cash Flow$75.7M

Return on Equity13.8%

Debt / Equity0.30x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Dorman Products, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Aug 9, 2026. Forensic signals flag probability, not certainty.